Counterpoint Quantitative Equity ETF (NYSEARCA:CPAI) Sees Significant Drop in Short Interest

Counterpoint Quantitative Equity ETF (NYSEARCA:CPAI) was the recipient of a significant drop in short interest in the month of May. As of May 31st, there was short interest totalling 7,000 shares, a drop of 69.8% from the May 15th total of 23,200 shares. Approximately 0.3% of the shares of the company are short sold. Based on an average trading volume of 12,700 shares, the short-interest ratio is currently 0.6 days.

Counterpoint Quantitative Equity ETF Price Performance

Shares of CPAI traded down $0.29 during midday trading on Friday, hitting $35.08. 5,290 shares of the company traded hands, compared to its average volume of 10,691. Counterpoint Quantitative Equity ETF has a one year low of $28.33 and a one year high of $37.55. The firm has a market cap of $83.14 million, a P/E ratio of 24.30 and a beta of 0.83. The stock has a 50-day moving average of $33.54 and a 200-day moving average of $34.59.

Institutional Investors Weigh In On Counterpoint Quantitative Equity ETF

Institutional investors and hedge funds have recently made changes to their positions in the business. Counterpoint Mutual Funds LLC grew its position in Counterpoint Quantitative Equity ETF by 49.8% during the fourth quarter. Counterpoint Mutual Funds LLC now owns 1,083,546 shares of the company’s stock worth $37,212,000 after buying an additional 360,270 shares in the last quarter. Avantax Advisory Services Inc. grew its holdings in shares of Counterpoint Quantitative Equity ETF by 277.1% during the first quarter. Avantax Advisory Services Inc. now owns 44,334 shares of the company’s stock worth $1,485,000 after purchasing an additional 32,577 shares in the last quarter. U.S. Capital Wealth Advisors LLC purchased a new stake in Counterpoint Quantitative Equity ETF in the first quarter valued at approximately $781,000. Jaffetilchin Investment Partners LLC purchased a new stake in Counterpoint Quantitative Equity ETF in the fourth quarter valued at approximately $643,000. Finally, Envestnet Asset Management Inc. bought a new stake in Counterpoint Quantitative Equity ETF during the first quarter valued at approximately $442,000.

Counterpoint Quantitative Equity ETF Company Profile

The Counterpoint Quantitative Equity ETF (CPAI) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, seeking long-term capital appreciation through a quantitative, model-based approach to select US stocks of any market capitalization. CPAI was launched on Nov 28, 2023 and is issued by Counterpoint.